Search results
Novavax (NASDAQ:NVAX) PT Raised to $18.00
ETF DAILY NEWS· 2 days agoNovavax (NASDAQ:NVAX – Get Free Report) had its target price increased by Bank of America from $12.00 to $18.00 in a research report issued to clients and investors on Friday ...
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC News via Yahoo News· 4 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
Is It Too Late to Buy Novavax Stock? | The Motley Fool
The Motley Fool· 4 days agoNovavax (NVAX -4.32%) stock is suddenly a buy again this year, with its stock price more than...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 4 days agoNovavax. Just be aware that the bullishness only goes so far. The consensus analyst price target on the healthcare stock is $17.50, which is only about...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 7 days agoThe Sanofi partnership removes a lot of the risk associated withNovavax stock and should help the...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 3 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 7 days agoThe S&P 500 rose to a record high earlier this year, confirming its presence in a bull market, and...
Is It Too Late to Buy Novavax Stock?
The Motley Fool via AOL· 4 days agoNovavax. Just be aware that the bullishness only goes so far. The consensus analyst price target on the healthcare stock is $17.50, which is only about 9% higher than the ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 3 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Short Interest in Novavax, Inc. (NASDAQ:NVAX) Drops By 15.6%
ETF DAILY NEWS· 3 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest ...
